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d Cartilage 20 (2012) S54–S296 S111ĂFigure 1: COP manipulation was accomplished using a platform in the
form of a shoe in which 2 adjustable convex-shaped biomechanical
elements are attached to the feet by means of a shoe sole specially
designed with 2mounting rails. One element is located under the hindfoot
and the other under the forefoot, enabling continuous positioning of each
element in multiple planes.
Results: Peak one of stance phase external adduction moment was not
signiﬁcant, however adduction angle at the time of peakmoment decreased
115% (p¼0.008) from L-COP to M-COP. In addition a signiﬁcant correlation
was found between peak one of the adduction moment and the associated
adduction/abduction angle (p¼0.005, r¼0.81). Peak stance phase adduction
angle decreased 106% (p¼0.012) from L-COP to M-COP (Table 1).
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Mean(SD) of coronal-plane gait kinematics [o] for L-COP and M-COP.
L-COP M-COP
Adduction/Abduction Angle@ Pk 1
Adduction Moment
3.62(3.23) -0.56(10.78)
Peak Adduction Angle 3.88(3.13) -0.22(10.55)Conclusions: In accordance with our hypothesis, coronal COP manipula-
tion signiﬁcantly altered gait parameters associated with the hip. The
results may have clinical implications for hip OA. Hip OA patients maywalk
with decreased external adduction moment, which may reduce load on
the joint. In addition they may shift their center of mass over the affected
joint in an effort to compensate for weak abductor muscles, better support
the load, and avoid pain. These gait compensationsmay be implemented at
a cost of an asymmetric gait that is detrimental to other joints of the trunk
and lower limbs. A decrease in adduction angle was observed with
a medial COP and was signiﬁcantly correlated with decrease in peak one of
the adduction moment. Thus, it is possible that a medial COP may provoke
a more normal gait by supporting the patient during gait, providing more
stability, and reducing pain. In later stages of rehabilitation, it may be
beneﬁcial to adopt a lateral COP which may provoke gait that more closely
resembles gait of healthy subjects by increasing gait parameters that are
decreased due to pathology. This remains to be shown in hip OA patients.
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A NEW NON-INVASIVE BIOMECHANICAL THERAPY FOR KNEE
OSTEOARTHRITIS IMPROVES CLINICAL SYMPTOMS AND GAIT PATTERNS
A. Elbaz 1, A. Mor 1, G. Segal 1, M. Drexler 2, D. Norman 3, E. Peled 3,
N. Rozen 4. 1AposTherapy research group, Herzliya, Israel; 2Dept. of
Orthopedic Surgery, Sourasky Med. Ctr., Tel-Aviv, Israel; 3Dept. of
Orthopedic Surgery, Rambam Med. Ctr., Haifa, ISRAEL; 4Dept. of Orthopedic
Surgery, HaEmek Med. Ctr., Afula, Israel
Purpose: The management of knee osteoarthritis (OA) focuses on reducing
the levels of pain and disability. Recently, a novel biomechanical device and
treatment methodology (AposTherapy) was shown to reduce knee adduc-
tion moment while simultaneously challenging the neuromuscular control
system through perturbation. The purpose of the study was to investigate
the changes in gait patterns and clinical measurements following treatment
with a novel biomechanical device on patients with knee OA.
Methods: 745 patients with bilateral knee OA were analyzed. Patients
completed a gait test, Western Ontario and McMaster Osteoarthritis Index
(WOMAC) questionnaire and SF-36 Health Survey at baseline and after
12 weeks. The biomechanical device was individually calibrated to each
patient. Shifting the center of pressure, through changes in the location ofthe biomechanical elements causes realignment and reduction in knee
adduction moment.. Furthermore the conﬁguration of the biomechanical
element allows training under controlled perturbation.
Results: A signiﬁcant decrease was found in WOMAC pain (28.6%) and
WOMAC function (25.2%) following three months of therapy (p<0.001).
A signiﬁcant increasewas found in thepatients' physical qualityof life (17.8%)
and mental quality of life (11.0%) (p<0.001). Gait velocity, cadence step
length, stance phase and single limb support phase improved signiﬁcantly
following three months of therapy (7.6%, 4.0%, 3.7% and 1.6%, respectively).
Conclusions: Our results suggest an overall improvement in the gait
patterns, level of pain, function and quality of life of patients with knee OA
following three months of AposTherapy.
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A NON-INVASIVE TREATMENT (APOSTHERAPY) ACCELERATES THE
REHABILITATION TIME OF PATIENTS FOLLOWING TOTAL HIP
ARTHROPLASTY. A PROSPECTIVE STUDY
G. Segal 1, Y. Bar-Ziv 2, S. Velkes 3, V. Benkovich 4, G. Stanger 1, E.M.
Debbi 1, R. Debi 5, A. Mor 1, A. Elbaz 1. 1AposTherapy Res. Group, Herzliya,
Israel; 2Orthopedic Dept., Assaf HaRofeh Med. Ctr., Zeriﬁn, Israel;
3Orthopedic Dept., Rabin Med. Ctr., Petah Tikva, Israel; 4Orthopedic Dept.,
Soroka Med. Ctr., Beer Sheva, Israel; 5Orthopedic Dept., Barzilay Med. Ctr.,
Ashkelon, Israel
Purpose:Patients following total hip arthroplasty often do not restore
normal gait patterns not do they return to normal levels of pain,
function and quality of life. The purpose of the current study was to
examine the effect of a new biomechanical rehabilitation therapy on
the clinical measurements, gait patterns and gait symmetry of patients
with total hip arthroplasty
Methods: Nineteen patients who were an average of 3 months post total
hip arthroplasty were enrolled to the study. Patients underwent
a computerized gait analysis and a time up and go test. Patients were also
asked to complete the Western Ontario and McMaster Universities osteo-
arthritis index and the SF-36 health survey. Patients then began therapy
with a non-invasive biomechanical device coupled with a treatment
methodology (AposTherapy) that allows patients to exercise under reduced
loads and promotes perturbations throughout the step cycle. Follow-up
examinations were conducted after 4, 12 and 26 weeks of therapy.
Results: After 26 weeks of therapy a signiﬁcant improvement was seen in
most gait parameters, including velocity (50.3%), involved step length
(22.9%) and involved single limb support (16.5%). A signiﬁcant improve-
ment was also found in the self-evaluation questionnaires, including
a signiﬁcant reduction in pain (85.4%) and improvement in function (81.1%)
and quality of life (52.1%).
Conclusions: Based on the results of this study, the application of such
a therapy should be considered in the rehabilitation of patients following
total hip arthroplasty.
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RELATIONSHIPS BETWEEN DEGENERATIONS OF ANTERIOR CRUCIATE
LIGAMENT AND OSTEOARTHRITIS
M. Chu, Y. Pang, B. Lu, H. Chen, W. Sun, J. Dai, D. Shi, Q. Jiang. Ctr. of
Diagnosis and Treatment for joint disease, Nanjing, China
Purpose: To ﬁnd out the relationships between the degenerations of
anterior cruciate ligament (ACL) and cartilage of femur condyle.
Methods: Test 1: Immunohistochemical assay of asporin in the ACL of aged
patients with knee osteoarthritis (OA) and young people without knee
disease in Chinese Han population. Test 2: Measurement of varus angles of
knees in 15patientswithACL injurywhen theywere takingaweight-bearing
positions radiograph of the entire lower extremity. Test 3: Measurement of
telomere lengths ofmedial femoral condyle, lateral femoral condyle and ACL
by southern blot in the suffered knee of 6 knee osteoarthritis patients.
Results: Immunohistochemical studies of ACL revealed that aged patients
with knee osteoarthritis showed higher expression levels of asporin than
young people without knee disease. In 14 of 15 ACL rupture patients, the
injured knee showed higher varus angle than the unharmed knee in the
weight-bearing positions radiograph of the entire lower extremity; in one
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S112patient, the injured knee and the unharmed knee showed no difference in
varus angle. In 5 patients the measurement of telomere lengths showed
that telomere length of lateral femoral condyle >ACL >medial femoral
condyle; in one patient the measure showed telomere length of medial
femoral condyle >ACL > lateral femoral condyle.
Conclusions: From test 1, we found expression of asporin in ACL increased
in the OA patients, it suggested degeneration of ACL in the OA patients.
From test 2, we found that ACL injury would increase the varus angles of
the knee. From test 3, we found that senescent degree in osteoarthritis
knee is medial femoral condyle >ACL > lateral femoral condyle. We
infered that ACL might degenerate or get injured at ﬁrst, and then led to
knee varus, and led to osteoarthritis at last.ĂBone Biology
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FSTL3 MEDIATES EXERCISE-DRIVEN BONE FORMATION.
P. Perera. The Ohio State Univ., Columbus, OH, USA
Objective: Exercise promotes bone remodeling through well-coordinated
biochemical events. This is evident by the observations that bone forms in
response to mechanical loading and resorbs following sustained unload-
ing. Despite this well demonstrated phenomenon, how exercise drives the
mechanoresponsiveness in bone is still elusive. Here, we provide
evidences that Follistatin-like3 (FSTL3) could be a mechanoresponsive
protein that that takes part in the exercise-driven bone formation.
Methods: Institutional Animal Care and Use Committee at OSU approved
all experimental protocols. Female Sprague Dawley rats (12-14 wks, n¼10),
wild-type (WT, 10-12 wks, n¼10) or homozygous FSTL3-/- C57Bl/6 mice
(10-12 wks, n¼10) were subjected to exercise by treadmill walking at 12
M/min (rats) or 8 M/min (mice) for 45 min/day. Following 0, 2, 5 or 15 days
of exercise, animals were sacriﬁced and gene expression was analyzed by
quantitative real time polymerase chain reaction (qrtPCR), Western blots,
or immunohistochemistry of the trabecular bone/bone marrow at the
distal ends of femurs. Bone mineral apposition rates of wild type or FSTL3-
null mice were assessed using two ﬂuorochromes, Calcein and Alizarin
complexones injected on day 3 and 12, respectively, during the total
exercise period of 15 days. On day 15, femurs of the mice were excised,
acrylamide embedded, sectioned, and subjected to ﬂuorescence micros-
copy to examine bone remodeling. Statistical analysis was performed by
one-way ANOVA with Tukey's post hoc or T-test.
Results: Gene expression for Fstl3, Follistatin (Fst), Inhibin-Alpha (Inha),
Inhibin-Beta-A (Inhba), and -Beta-B (Inhbb) by qrtPCR revealed that
treadmill walking dramatically stimulated Fstl3 mRNA expression in the
trabecular bone and bonemarrowcells, reachingw6 fold increase on day 2
(p<0.05) and declining by day 5, in rats and mice. However, the expression
of Inha, Inhba, and Inhbb was unchanged (Fig 1A). In parallel, a robust
increase in FSTL3 expression was observed in cells adjacent to trabecular
bone, and in osteocalcin positive osteocytes located in cortical bone (Fig
1B). When Fstl3+/+ or Fstl3-/- mice were subjected to treadmill walking for
15 consecutive days, and injectedwith Calcein (day 3) and Alizarin (day 12)
bone incorporation revealed limited bone deposition in both groups of
non-exercised control mice. However, Fstl3+/+ mice when subjected to
treadmill walking demonstrated a signiﬁcant increase in bone deposition
on the periosteal surface of the femur together with increase in the total
mineral apposition rate (MAR;w50% increase, p< 0.05). Similar treatment
failed to induce exercise-induced bone formation and MAR increase in
Fstl3-/- mice. Furthermore, FSTL3 null mice exhibited weaker femurs
(ultimate strength FSTL3+/+ 3.20.4% vs. FSTL3-/- 2.40.3%, p<0.003) and
brittle bones (fracture strain FSTL3+/+ 7.73.4% vs. FSTL3-/- 51.3%, n ¼ 7,
p ¼ 0.037). Interestingly, circulating levels of FSTL3 increased in mice,
humans and rats following 2 days (5.21.3) and 5 days (6.41.1 fold) of
exercise, indicating a requirement of FSTL3 for the adaptive responses of
the bone to mechanical loading.
Conclusions: Overall, the data suggest that FSTL3 is the ﬁrst molecule
identiﬁed that might be critical for bone formation and strengthening in
response to mechanical loading of bones. This is evident by observations
that genomic deletion of FSTL3 abolishes load-dependent bone formation,
weakening of bones, and failure of upregulation of genes associated with
bone deposition. The identiﬁcation of FSTL3 as a mechanoresponsiveprotein provides a new paradigm for investigating exercise-driven bone
formation and its use as a target to develop therapeutic drugs for treating
bone diseases.
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A SPECIFIC SUBTYPE OF OSTEOCLASTS SECRETE FACTORS INDUCING
BONE FORMATION
K. Henriksen 1, K.V. Andreassen 1, C.S. Thudium1, N.S. Gudmann 1, A.C. Bay-
Jensen 1, I. Moscatelli 2, J. Richter 2, M.A. Karsdal 1, A.V. Neutzsky-
Wulff 1. 1Nordic BioSci. A/S, Herlev, Denmark; 2Dept. of Molecular Med.
and Gene Therapy, Lund Strategic Ctr. for Stem Cell Biology, Lund, Sweden
Purpose: Osteoclasts are known to be important for the coupling process
between bone resorption and formation, at least partially by secretion of
bone anabolic factor(s), a phenomenon which could be involved in the
subchondral plate thickening in OA .
The aims of this study were to address whether osteoclasts are the only
source of anabolic factors, and how the ability to resorb, as well as how
different matrices affect the release of bone anabolic factors from mature
resorbing osteoclasts.
Methods: Human monocytes were isolated from cord blood or periph-
eral blood and differentiated into mature osteoclasts by treatment with
M-CSF and RANKL. Conditioned medium was collected from macro-
phages, pre-osteoclasts, and mature functional and non-resorbing
osteopetrotic osteoclasts on either bone, plastic, decalciﬁed bone or
dentine. Osteoclasts on bone and plastic were treated with vehicle or
diphyllin, E64 or GM6001. Conditioned medium (CM) and corresponding
non-conditioned medium (non-CM) was collected and pooled. Osteo-
clasts numbers were measured by TRACP activity. Bone resorption was
evaluated by CTX-I and calcium release. The osteoblastic cell line 2T3
was treated with 50% of CM or non-CM for 12 days. Bone formation was
assessed by Alizarin Red extraction.
Results: Only CM from mature osteoclasts induced bone formation, while
CM from precursors or mature macrophages failed to do so. Non-resorbing
osteoclasts generated from osteopetrosis patients showed very little
resorption, yet a blunted, but still signiﬁcant ability to induce bone
formation by osteoblasts. Diphyllin and E64 all potently reduced resorp-
tion, while GM6001 did not. Collected CM from all the conditions induced
bone formation signiﬁcantly compared to their corresponding non-CM,
with an 800% induction by vehicle CM. However, CM from diphyllin,
cathepsin K inhibitor and E64 treated osteoclasts decreased the level of
bone formation compared to CM from vehicle treated osteoclasts by
approximately 50%, while CM from GM6001 treated osteoclasts equaled
vehicle CM. Osteoclasts on either dentine or decalciﬁed bone showed
strongly attenuated anabolic capacities.
Conclusion: We present evidence that osteoclasts, both dependent and
independent of their resorptive activity, secrete activities stimulating
osteoblastic bone formation. Further understanding of these processes
could shed light on the complicated interactions occuring in the sub-
chondral plate during osteoarthritis.
